Orange Book product · Brand (NDA)
TEPADINA AND SODIUM CHLORIDE
THIOTEPA
At a glance
Apr 10, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 10, 2025
1 yr 3 mo ago
Today
Patent 9931458 expires
Listed drug product patent expiration.
May 31, 2037
in 11 yr 1 mo
Pharmaceutical detail
Active ingredient
THIOTEPA
Strength
200MG
Dosage form
POWDER
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 208264
Product number
003
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2024TEPYLUTEBrand (NDA)
NDA 216984 · SHORLA
- 1994THIOPLEXBrand (NDA)
NDA 020058 · IMMUNEX
- —THIOTEPABrand (NDA)
NDA 011683 · IMMUNEX
- 2024THIOTEPAGeneric (ANDA)
ANDA 217559 · REGCON HOLDINGS
- 2023THIOTEPAGeneric (ANDA)
ANDA 216037 · MEITHEAL
- 2023THIOTEPAGeneric (ANDA)
ANDA 211755 · HIKMA
- 2021THIOTEPAGeneric (ANDA)
ANDA 211831 · REGCON HOLDINGS
- 2021THIOTEPAGeneric (ANDA)
ANDA 214222 · GLAND
- 2020THIOTEPAGeneric (ANDA)
ANDA 213049 · MSN
- 2020THIOTEPAGeneric (ANDA)
ANDA 208242 · PENN LIFE
- 2018THIOTEPAGeneric (ANDA)
ANDA 210337 · DR REDDYS
- 2018THIOTEPAGeneric (ANDA)
ANDA 209150 · HENGRUI PHARMA
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9931458 | May 31, 2037 | in 11 yr 1 mo | Product |

